Diabetic Kidney Disease Management and Outcomes
Summary
Diabetic kidney disease is a leading cause of chronic kidney impairment worldwide, affecting patients with both type 1 and type 2 diabetes. Early identification via routine screening of albuminuria and estimated glomerular filtration rate (eGFR) enables timely intervention. Core management strategies include optimised glycaemic control, blood pressure reduction—frequently employing renin–angiotensin system blockers—and incorporation of sodium–glucose co-transporter 2 inhibitors. Multifactorial risk factor modification, covering lipid regulation and lifestyle measures, has demonstrated efficacy in slowing progression to end-stage kidney disease (ESKD). Nevertheless, a subgroup of patients experiences rapid eGFR decline or persistent albuminuria despite these therapies. Advances in biomarker discovery and risk-prediction models aim to identify high-risk individuals who may benefit from intensified or personalised treatment. Emerging insights into mitochondrial dysfunction and inflammatory cascades promise to inform novel therapeutic avenues. Achieving improved outcomes and mitigating the global burden of diabetic kidney disease demands integration of early diagnosis, individualised care and continuous monitoring.
Research from Nature Portfolio
Longitudinal analyses of individuals with type 1 diabetes have delineated key clinical predictors for the onset of chronic kidney disease. Variables such as glycated haemoglobin, duration of diabetes, elevated triglycerides and blood pressure emerged as independent risk factors for developing reduced eGFR or albuminuria over five years. The study highlighted distinct determinants for the two main traits of kidney damage and underlined the importance of baseline renal function in prognostic models. These findings inform risk stratification, guiding intensive surveillance and early therapeutic intervention to delay progression towards stage G3–G5 chronic kidney disease.
Diabetic Kidney Disease Management and Outcomes publication trend
The graph below shows the total number of articles in diabetic kidney disease management and outcomes across all publications each year (not limited to Nature Index journals).
Technical terms
Estimated glomerular filtration rate (eGFR): A calculated index of kidney function based on serum creatinine, age and sex.
Albuminuria: The presence of albumin in urine, an early marker of glomerular damage.
End-stage kidney disease (ESKD): The final stage of kidney failure requiring dialysis or transplantation.
Glomerular basement membrane (GBM): The specialised extracellular matrix underlying capillary loops in the glomerulus.
References
- Attenuated kidney oxidative metabolism in young adults with type 1 diabetes. Journal of Clinical Investigation (2024).
- Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative. Scientific Reports (2017).
- Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus. Diabetologia (2019).
- Range of Risk Factor Levels, Risk Control, and Temporal Trends for Nephropathy and End-stage Kidney Disease in Patients With Type 1 and Type 2 Diabetes.. Diabetes Care (2022).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.